Saturday, July 11, 2026

Drug profile · INN

ibi3016

ibi3016 is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — ibi3016
Class
Route
Patents
0
Programs
1
Data quality
0.70

Quick answer

ibi3016 is an FDA-listed pharmaceutical active ingredient.

Key facts

INN ibi3016

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. IBI3016 Phase 2 · Innovent Biologics · Hypertension

Frequently asked questions

What is ibi3016?

ibi3016 is an FDA-listed pharmaceutical active ingredient.